Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 305-1870, Iss. 11, 2015-11 ,pp. : 1152-1157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 32, Iss. 7, 2016-10 ,pp. : 685-693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

By Manghat P.   Fraser W.   Wierzbicki A.   Fogelman I.   Goldsmith D.   Hampson G.  

Osteoporosis International, Vol. 21, Iss. 11, 2010-11 ,pp. : 1853-1861

Springer Publishing Company

Access to resources Recommend Favorite

A prospective study of fibroblast growth factor-23 in children with chronic kidney disease

By Magnusson Per   Hansson Sverker   Swolin-Eide Diana  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 1, 2010-02 ,pp. : 15-20

Informa Healthcare

Access to resources Recommend Favorite

Fibroblast Growth Factor 23/Klotho Axis in Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 128, Iss. 1-2, 2014-11 ,pp. : 1-10

Karger

Access to resources Recommend Favorite